Instituto De Investigaciones Neuropsiquiatricas Doctor Lopez Ibor S.A.
- Address
- Calle Del Doctor Juan Jose Lopez Ibor 2, 28035 Madrid, Spain
Psychiatry and Psychology at Instituto De Investigaciones Neuropsiquiatricas Doctor Lopez Ibor S.A.
This research site in Madrid is focused on mental disorders, with clinical trials centered on bipolar depression. The studies are designed to better understand how a new treatment may help people experiencing depressive episodes linked to bipolar I or II disorder.
- Evaluating the effectiveness and safety of a new therapy for bipolar depression
- Studying longer-term treatment use to understand safety and tolerability in mood disorders
The site’s work reflects a clear emphasis on improving care for people living with depressive episodes associated with bipolar disorder, combining treatment assessment with ongoing attention to patient well-being.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Xenon Pharmaceuticals Inc.2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Xenon Pharmaceuticals Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Instituto De Investigaciones Neuropsiquiatricas Doctor Lopez Ibor S.A.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Long-term, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Azetukalner in Patients with Bipolar I or II Depression | Xenon Pharmaceuticals Inc. | Phase III | Not Yet Recruiting | — | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azetukalner | 2 | Unknown | 2026-06-05 | 2026-06-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.